Iuamoto Leandro Ryuchi, Franco André Silva, Suguita Fábio Yuji, Essu Felipe Futema, Oliveira Lucas Torres, Kato Juliana Mika, Torsani Matheus Belloni, Meyer Alberto, Andraus Wellington, Chaib Eleazar, D'Albuquerque Luiz Augusto Carneiro
Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Departamento de Gastroenterologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Clinics (Sao Paulo). 2017 Apr;72(4):238-243. doi: 10.6061/clinics/2017(04)08.
Among the innovations for the treatment of type 1 diabetes, islet transplantation is a less invasive method of treatment, although it is still in development. One of the greatest barriers to this technique is the low number of pancreas donors and the low number of pancreases that are available for transplantation. Rodent models have been chosen in most studies of islet rejection and type 1 diabetes prevention to evaluate the quality and function of isolated human islets and to identify alternative solutions to the problem of islet scarcity. The purpose of this study is to conduct a review of islet xenotransplantation experiments from humans to rodents, to organize and analyze the parameters of these experiments, to describe trends in experimental modeling and to assess the viability of this procedure. In this study, we reviewed recently published research regarding islet xenotransplantation from humans to rodents, and we summarized the findings and organized the relevant data. The included studies were recent reports that involved xenotransplantation using human islets in a rodent model. We excluded the studies that related to isotransplantation, autotransplantation and allotransplantation. A total of 34 studies that related to xenotransplantation were selected for review based on their relevance and current data. Advances in the use of different graft sites may overcome autoimmunity and rejection after transplantation, which may solve the problem of the scarcity of islet donors in patients with type 1 diabetes.
在1型糖尿病的治疗创新方法中,胰岛移植是一种侵入性较小的治疗方法,尽管它仍在研发中。这项技术最大的障碍之一是胰腺供体数量少以及可用于移植的胰腺数量少。在大多数胰岛排斥和1型糖尿病预防研究中,已选择啮齿动物模型来评估分离出的人胰岛的质量和功能,并确定解决胰岛稀缺问题的替代方案。本研究的目的是对从人到啮齿动物的胰岛异种移植实验进行综述,整理和分析这些实验的参数,描述实验建模的趋势,并评估该程序的可行性。在本研究中,我们回顾了最近发表的关于从人到啮齿动物的胰岛异种移植的研究,并总结了研究结果并整理了相关数据。纳入的研究是最近涉及在啮齿动物模型中使用人胰岛进行异种移植的报告。我们排除了与同基因移植、自体移植和同种异体移植相关的研究。根据其相关性和现有数据,共选择了34项与异种移植相关的研究进行综述。不同移植部位使用方法的进展可能会克服移植后的自身免疫和排斥反应,这可能解决1型糖尿病患者胰岛供体稀缺的问题。